Category: W.L. Gore & Associates
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds NuVasive patent win over Medtronic; Appeals court won't revisit Bard's $1B win over W.L. Gore; Ex-Boston Scientific engineer cops to stealing catheter secrets; AngioDynamics wants court to enforce $160m Biolitec judgment
A federal appeals court declines to re-hear a January ruling that added more than $200 million to W.L. Gore & Assoc.'s $854 million tab in their stent graft patent war.
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court puts Gore on the hook for $1B in damages to Bard; Bard loses bid to delay pelvic mesh cases over judge's comments; Johnson & Johnson: Women asked to lie for pelvic mesh payoffs; BD notches partial win in $352m anti-trust loss to Retractable Technologies
A federal appeals court today ruled that W.L. Gore & Assoc. owes C.R. Bard $1 billion in penalties and damages for infringing a stent graft patent.
Gore Medical receives CE Mark approval in the European Union for its Viabahn vascular device for the treatment of obstructed peripheral veins in hemodialysis patients.
Gore Medical said it received CE Mark approval for its Viabahn vascular device for the treatment of obstructed peripheral veins in hemodialysis patients.
The Flagstaff, Ariz.-based company said the approval covers the treatment of obstructed peripheral veins, excluding the venae cavae and pulmonary veins.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA guides on custom devices; FDA approves Gore's Viabahn for peripheral stent repair; Alcon wins date with FDA panel for AcrySof lens; FDA seeks public input on medtech hacking; ReFlow Medical wins CE Mark for crossing catheters;
The FDA adds an indication to its approval of W.L. Gore's Viabahn peripheral stent graft in treating failed bare-metal stents.
W.L. Gore & Assoc. said the FDA granted pre-market approval for a new indication for its Viabahn endoprosthesis, to treat failed bare-metal stents in the peripheral vasculature.